🔴 Neumora Therapeutics, Inc. is trading 9.9% down today, extending recent volatility after last week’s extreme swings

Neumora Therapeutics, Inc. is trading 9.9% down at $1.36 in pre-market, extending its recent volatility after last week’s extreme swings.

• The decline appears to be driven by follow-through trading and sentiment-driven action rather than a new, clearly identified catalyst.
• No fresh company-specific filings, FDA decisions, or analyst calls have been released overnight to explain the move.
• Broader equity futures are only slightly changed, suggesting the price action is isolated to the stock's recent momentum.